We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Specific Proteins in Urine Help Diagnose Kawasaki Disease

By LabMedica International staff writers
Posted on 28 Jan 2013
A set of proteins detected in urine of patients with Kawasaki disease could make the disease easier to diagnose and give doctors an opportunity to start treatment earlier.

Susan Kim, MD, MMSc, a rheumatologist with the Kawasaki Disease Program at Boston Children’s Hospital (Boston, MA, USA) worked with proteomics experts Alex Kentsis, MD, PhD, and Hanno Steen, PhD, to screen the protein content of urine from patients with Kawasaki disease using mass spectrometry and enzyme-linked immunosorbant assays. More...


The team identified 190 proteins found only in the urine of children with Kawasaki disease. When validated in samples from 107 children seen at Boston Children’s with suspected Kawasaki disease (53 of whom were ultimately diagnosed with it), two of the proteins—filamin C and meprin A, which are associated with injury to blood vessel and cardiac muscle cells as well as inflammation—proved to be 98% accurate at distinguishing children with Kawasaki disease from ones with conditions mimicking the disease. Levels of the markers also closely tracked treatment response and in one patient, disease recurrence

Other Kawasaki-associated markers detected in the study included proteins involved in immune activation, immune regulation, and pathogen recognition. The researchers caution that for the moment the markers are still research tools and that they are working to refine and validate the findings in a larger group of patients.

The discovery was reported online by a team led by members of the proteomics center and the departments of pathology and rheumatology at Boston Children’s Hospital on December 20, 2012, in the journal EMBO Molecular Medicine.

Kawasaki disease is an uncommon but increasingly prevalent disease, which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children. While only about two in 10,000 children in the United States develop Kawasaki disease annually, the disease is on the rise worldwide; in Japan the prevalence approaches one in 100 among children under the age of five. No one knows what triggers the disease, and though it can occur at any age, it most often appears in children under five.

Related Links:

Boston Children’s Hospital




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
Pipette
Accumax Smart Series
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.